Validity and reliability of Korean version of simplified nutritional appetite questionnaire in patients with advanced cancer: A multicenter, longitudinal study.

2017 ◽  
Vol 35 (31_suppl) ◽  
pp. 211-211
Author(s):  
Su-Jin Koh ◽  
So Yeon Oh ◽  
Ji Yeon Baek ◽  
Kyung A. Kwon ◽  
Hei-Cheul Jeung ◽  
...  
Keyword(s):  
Weight Loss ◽  
Cancer Patients ◽  
Correlation Coefficient ◽  
Advanced Cancer ◽  
Screening Tool ◽  
Intraclass Correlation ◽  
Validity And Reliability ◽  
Advanced Cancer Patients ◽  
Korean Version ◽  
The Mean

211 Background: Malnutrition and a loss of muscle mass are frequent in cancer patients and have a negative effect on clinical outcome. Nutrition risk screening aims to increase awareness and allow early recognition and treatment of cancer cachexia. Therefore, screenings should be brief, inexpensive, highly sensitive, and have good specificity. SNAQ is a simple screening tool including 4 questions, and validated to predict weight loss within 6 months in community-dwelling adults and nursing home residents. Our study aimed to translate the SNAQ into Korean, and to assess the validity and reliability of the translated screening tool in advanced cancer patients. Methods: The SNAQ was translated into Korean according to linguistic validation. The internal consistency of the SNAQ was evaluated by Cronbach’s alpha coefficient. Test–retest reliability was evaluated using the intraclass correlation coefficient. Concurrent validity was evaluated by measuring the Pearson’s correlation coefficient between the SNAQ and Mini-Nutritional Assessment (MNA) and Patient-Generated Subjective Global Assessment (PG-SGA). Results: In the 194 patients included in full analysis set, cancer stage was predominantly (98.5%) metastatic, the mean age was 60 years, and the mean BMI was 24 kg/m2. According to MNA score ≤11, 57 patients (29.3%) were malnourished. The mean score of the Korean version of the SNAQ was 13.8 (SD = 2.5) with a range of 6–19. Cronbach’s alpha coefficient was 0.74, and intraclass correlation coefficient was 0.87. The SNAQ was moderately correlated with MNA(r = 0.4043, p < 0.0001) and PG-SGA(r = -0.5297, p < 0.0001). A significant weight loss of 5% of the original body weight within 6 months occurred in 46 (24.7%) of the 186 patients. SNAQ score ≤14 predicted 5% weight loss with a sensitivity of 56.5% and a specificity of 44.3%. Conclusions: The Korean version of the SNAQ had high validity and reliability. SNAQ is useful for the screening tool for advanced cancer patients. The SNAQ had a limitation to predict impending weight loss in advanced cancer patients.

Development of the Opioid Self-Management Scale for Advanced Cancer Patients and Examination of its Validity and Reliability

2021 ◽  
Author(s):  
Shiori Yoshida ◽  
Fumiko Sato ◽  
Keita Tagami ◽  
Rie Sasaki ◽  
Chikako Takahashi ◽  
...  
Keyword(s):  
Pain Relief ◽  
Cancer Patients ◽  
Advanced Cancer ◽  
Goodness Of Fit ◽  
Intraclass Correlation ◽  
Self Management ◽  
Equation Modeling ◽  
Validity And Reliability ◽  
Advanced Cancer Patients ◽  
Fit Index

Abstract Background: Approximately 60% of outpatients with advanced cancer experience pain, and self-management with opioids according to lifestyle is important for appropriate pain relief. To date, there are no studies that clearly describe the concept of opioid self-management or that have assessed the factors involved, such as improving self-management abilities. This study developed the Opioid Self-Management Scale for Advanced Cancer Patients (OSSA), and examined its validity and reliability.Methods: The scale was developed in three phases. In phase 1 the scale content was validated. In phase 2 surface validity was examined. The surface validity was examined using a draft scale that extracted qualitatively and deductively. Phase 3 validated and verified the reliability of the OSSA. The validity and reliability were examined using a factor analysis and re-testing.Results: The OSSA consists of 33 items on six subscales. The structural equation modeling was such that the χ2 value was 709.8 (p<.001, df = 467), goodness-of-fit index 0.78, adjusted goodness-of-fit index 0.73, root mean squares of approximation 0.063, and comparative fit index 0.92. Cronbach’s α was 0.93. The intraclass correlation coefficient was 0.59–0.90. The coefficient was -0.21 (p<0.05) for the total OSSA score and “Average pain over 24 hours,” and 0.26 (p<0.01) for “Rate of pain relief over 24 hours.”Conclusion: We determined that the OSSA had tolerable validity and reliability, and the results indicated that a higher self-management ability leads to greater pain relief. The OSSA scales can be considered effective for use in research. A shortened version of the OSSA is required for realistic and practical clinical use.

The Relationship Between a Urinary Cachectic Factor and Weight Loss in Advanced Cancer Patients

2004 ◽  
Vol 22 (6) ◽  
pp. 866-870 ◽  
Author(s):  
M. L. Williams ◽  
A. Torres-Duarte ◽  
L. J. Brant ◽  
P. Bhargava ◽  
J. Marshall ◽  
...  
Keyword(s):  
Weight Loss ◽  
Cancer Patients ◽  
Advanced Cancer ◽  
Advanced Cancer Patients ◽  
The Relationship

scholarly journals Weight Loss and Gastrointestinal Symptoms in Advanced Cancer Patients Treated with Platinum-based Chemotherapy

2020 ◽  
Vol 5 (2) ◽  
pp. 97-104
Author(s):  
Hui Gao ◽  
Dong Bo Liu ◽  
Jin Tong ◽  
Jing Han ◽  
Bo Liu ◽  
...  
Keyword(s):  
Weight Loss ◽  
Cancer Patients ◽  
Advanced Cancer ◽  
Gastrointestinal Symptoms ◽  
Advanced Cancer Patients ◽  
Platinum Based Chemotherapy

PP075-SUN MORE THAN 5% WEIGHT LOSS BEFORE CHEMOTHERAPY PREDICTS LOSS OF FAT FREE MASS DURING TREATMENT IN ADVANCED CANCER PATIENTS

2011 ◽  
Vol 6 (1) ◽  
pp. 52
Author(s):  
S. Buskermolen ◽  
J. Langius ◽  
H. Kruizenga ◽  
G. Ligthart-Melis ◽  
M. Heymans ◽  
...  
Keyword(s):  
Weight Loss ◽  
Cancer Patients ◽  
Advanced Cancer ◽  
Fat Free Mass ◽  
Advanced Cancer Patients

Secondary vs. primary cachexia in patients with advanced cancer

2007 ◽  
Vol 25 (18_suppl) ◽  
pp. 9128-9128 ◽  
Author(s):  
E. Del Fabbro ◽  
S. Dalal ◽  
M. Delgado ◽  
G. Freer ◽  
E. Bruera
Keyword(s):  
Weight Loss ◽  
Cancer Patients ◽  
Advanced Cancer ◽  
Oral Candidiasis ◽  
Comprehensive Cancer Center ◽  
Cancer Center ◽  
Clinical Effects ◽  
Advanced Cancer Patients ◽  
Early Satiety ◽  
Secondary Causes

9128 Background: Cachexia results in decreased survival and adherence to chemotherapy, and increased treatment toxicity. Primary Cachexia (PC) is characterized by weight loss, anorexia and fatigue and it is the result of tumor-host interactions producing neurohormonal dysfunction and an aberrant pro-inflammatory response. The clinical effects of PC may be exacerbated by complications capable of decreasing energy intake (Secondary Cachexia) such as dysgeusia, anxiety, depression, pain, early satiety, nausea and constipation. The objective of this study was to determine the causes and the frequency of secondary cachexia (SC) in a cohort of patients with PC. Methods: We reviewed the charts of 50 consecutive advanced cancer patients who underwent a structured assessment in a specialized cachexia clinic at a comprehensive cancer center. Results: All patients gathered criteria for cachexia, including a weight loss of >5% within the preceding 6 months. The most frequent causes of SC were early satiety in 40 patients(80%), constipation in 37(74%), depression or anxiety in 30(60%), uncontrolled pain in 31(62%), chronic nausea in 21(42%), dysgeusia in 14(28%),dental problems in 4(8%), dysphagia in 3(6%)chronic aspiration in 2 (4%) and oral candidiasis in 1 (2%).All 50 patients presented with at least 2 secondary causes of cachexia, and 44(88%) presented with = 3. The median number of causes of secondary cachexia was 4 (range 2–5). 211 interventions were used in these patients to treat secondary causes of cachexia. 14(28%) of the patients referred were already on a medication for appetite stimulation (megestrol acetate, dronabinol, corticosteroids). Conclusions: SC should be ruled out in all patients who have PC since the vast majority of patients referred to a cachexia clinic have 2 or more causes of SC. All cancer patients with involuntary weight loss in our series had “mixed cachexia”. Inexpensive effective treatments are available for most of the causes of SC, but they are frequently underused. No significant financial relationships to disclose.

scholarly journals Episodic Breathlessness with and without Background Dyspnea in Advanced Cancer Patients Admitted to an Acute Supportive Care Unit

Cancers ◽  
2020 ◽  
Vol 12 (8) ◽  
pp. 2102
Author(s):  
Sebastiano Mercadante ◽  
Claudio Adile ◽  
Patrizia Ferrera ◽  
Giuseppe Bonanno ◽  
Vincenzo Restivo ◽  
...  
Keyword(s):  
Cancer Patients ◽  
Advanced Cancer ◽  
Depression Scale ◽  
Anxiety And Depression ◽  
Hospital Anxiety ◽  
Advanced Cancer Patients ◽  
Clinical Appearance ◽  
Factors Influencing ◽  
Numerical Scale ◽  
The Mean

Aim: To characterize episodic breathlessness (EB) in patients with advanced cancer, and to determine factors influencing its clinical appearance. Methods: A consecutive sample of advanced cancer patients admitted to an acute palliative care unit was surveyed. Continuous dyspnea and EB were measured by a numerical scale. The use of drugs used for continuous dyspnea and EB was recorded. Patients were asked about the characteristics of EB (frequency, intensity, duration and triggers). The Multidimensional dyspnea profile (MDP), the Brief dyspnea inventory (BDI), the Athens sleep scale (AIS) and the Hospital Anxiety and Depression Scale (HADS) were also administered. Results: From 439 advanced cancer patients surveyed, 34 and 27 patients had EB, without and with background dyspnea, respectively. The mean intensity and the number of episodes were higher in patients with background dyspnea (p < 0.0005 and p = 0.05, respectively). No differences in duration were observed. Most episodes lasted <10 min. A recognizable cause triggering EB was often found. The presence of both background dyspnea and EB was associated with higher values of MDP and BDI. EB was independently associated with frequency and intensity of background dyspnea (OR = 20.9, 95% CI (Confidence interval) 9.1–48.0; p < 0.0005 and OR = 1.97, 95% CI 1.09–3.58; p = 0.025, respectively) and a lower Karnofsky level (OR = 0.96, 95%CI 0.92–0.98, p = 0.05). Discussion: EB may occur in patients with and without continuous dyspnea, and is often induced by physical and psychological factors. EB intensity is higher in patients with continuous dyspnea. The duration was often so short that the use of drugs, as needed, may be too late, unless administered pre-emptively when the trigger was predictable.

scholarly journals Validity and Reliability of the Persian Version of Emotion Thermometers in Iranian Advanced Cancer Patients

2019 ◽  
Vol 12 (7) ◽  
Author(s):  
Neda Shahvaroughi Farahani ◽  
Malek Bastami ◽  
Mahdi Alemrajabi ◽  
Hanieh Alasty ◽  
Mohaddeseh Rajabi
Keyword(s):  
Cancer Patients ◽  
Advanced Cancer ◽  
Validity And Reliability ◽  
Advanced Cancer Patients ◽  
Persian Version

Validity and Reliability of the Family Inventory of Needs (FIN): Measuring the Care Needs of Families of Advanced Cancer Patients

1995 ◽  
Vol 3 (2) ◽  
pp. 109-126 ◽  
Author(s):  
Linda J. Kristjanson ◽  
Jan Atwood ◽  
Lesley F. Degner
Keyword(s):  
Construct Validity ◽  
Cancer Patients ◽  
Advanced Cancer ◽  
Internal Consistency ◽  
Family Members ◽  
Validity And Reliability ◽  
Alpha Coefficient ◽  
Advanced Cancer Patients ◽  
Care Needs ◽  
The Family

Two studies balanced qualitative and quantitative data to provide evidence of satisfactory validity and reliability of the Family Inventory of Needs (FIN). The FIN is designed to measure the importance of care needs of families of advanced cancer patients (FIN-Importance of Care Needs subscale) and the extent to which families perceive that their care needs have been met (FINFulfillment of Care Needs subscale). The first study involved development of the instrument and testing for clarity, apparent internal consistency (nonquantitative assessment of homogeneity of content), and content validity using a panel of six experts (family members of advanced cancer patients). The FIN met or exceeded the preset criteria specified used in this phase of testing. The second study of the project used 109 family members of advanced cancer patients from three hospice programs to test the FIN for internal consistency and construct validity. Internal consistency of the FIN-Importance of Care Needs subscale as measured by Cronbach’s alpha coefficient was .83 without redundancy. Construct analysis was assessed using factor analysis techniques. An inability to extract a substantively meaningful minimum number of factors, together with the fact that a theta reliability coefficient of .85 was obtained (only .02 higher than the alpha coefficient), suggested that the items were parallel supporting the conclusion that the subscale is unidimensional. Support for the construct validity of the FINImportance of Care Needs subscale was also obtained using predictive modeling. The internal structure of the FIN-Fulfillment of Care Needs subscale was assessed using cluster analysis. Results suggested that the subscale is a unidimensional one. Overall, the FIN met the preset reliability and validity criteria providing promising evidence for the instrument’s sound psychometric properties for use in research and clinical settings.

scholarly journals Validation of Hospital Anxiety and Depression Scale as a screening tool for psychological distress in advanced cancer patients undergoing chemotherapy

2011 ◽  
Vol 6 (2) ◽  
pp. 150-157
Author(s):  
Keita Uchino ◽  
Hitoshi Kusaba ◽  
Junji Kishimoto ◽  
Hiroshi Mitsuyasu ◽  
Hiroaki Kawasaki ◽  
...  
Keyword(s):  
Psychological Distress ◽  
Cancer Patients ◽  
Advanced Cancer ◽  
Screening Tool ◽  
Depression Scale ◽  
Anxiety And Depression ◽  
Hospital Anxiety ◽  
Advanced Cancer Patients
Sign in / Sign up

Export Citation Format

Share Document